Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc

Bullboard Posts

Comment by TechnicallyHighon Mar 26, 2019 12:59pm

22 Views

Post# 29537462

RE:no drug store chain

LongandDong wrote: will stock 100 million worth of synthetic cbd with no market for it

Basta!!!

Wow.. misinformation much? They are being onboarded by Shoppers Drug Mart and having meetings with LP's as strategics who are STARVING for CBD.

oh and beverage companies..

Youre attempt to create a nonsense short thesis is as desperate as it is based in nothing. Think about it this way.. Noramco is the one making the CBD to which Cardiol licenses Canada and Mexico distribution. To say Cardiol has no market, is to say Noramco has no market.

Moronic stockhouse shorters trying to speak on things they have no idea about... good luck with that.

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”